September 2016 – Page 2 – Policy & Medicine

PDUFA IV: Full Steam Ahead?

Legislation Introduced to Modify Hospital Quality Star Ratings Release

On a Collision Course – FDA Clinical Investigator Disclosure and Open Payments

New Rule and Guidance Issued on Clinical Trials

Webinar – Next Generation Compliance: Using Analytics to Reduce Compliance Risk

Mylan Pricing Summary: A Case Study in Increases

New OIG Guidance on IRO Independence and Objectivity

State of the European Union – Transparency in Europe 2016 and Beyond

ABIM and ACCME Expand Collaboration

GAO Issues Report on Generic Drug Price Increases